NCT00186979View on ClinicalTrials.gov

Study of ZD1839 Combined With Irinotecan and Vincristine in Pediatric Patients With Refractory Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Solid Tumors
Interventions
DRUG

Irinotecan, ZD1839, Vincristine, Cefixime, Cefpodoxime.

See Detailed Description section for details of treatment interventions.

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

National Institutes of Health (NIH)

NIH

lead

St. Jude Children's Research Hospital

OTHER